Bli medlem
Bli medlem

Du är här


RaySearch Laboratories: Conversion of shares in RaySearch Laboratories AB (publ)

During March 2016, 750 Class A shares were converted to Class B
shares, at the request of a shareholder. The total number of votes in
RaySearch thereafter amounts to 126,641,349 votes. The total number
of registered shares in RaySearch amounts to 34,282,773 shares, of
which 10,262,064 are Class A shares and 24,020,709 are Class B

According to RaySearch Laboratories AB (publ)'s Articles of
Association, owners of Class A shares have the right to have such
shares converted to Class B shares. A conversion reduces the number
of votes in the company. When a conversion has been carried out,
RaySearch is obligated by law to disclose information on the changes
occurred by the conversion.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that
develops advanced software solutions for improved radiation therapy
of cancer. RaySearch markets the RayStation® treatment planning
system to clinics all over the world. In addition, RaySearch's
products are distributed through licensing agreements with leading
medical technology companies. RaySearch's software solutions are used
by over 2,600 clinics in more than 65 countries. RaySearch was
founded in 2000 as a spin-off from Karolinska Institutet in Stockholm
and the company is listed in the Mid Cap segment on NASDAQ OMX

For more information about RaySearch, visit

For further information please contact:
RaySearch Laboratories AB (publ)
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00

RaySearch discloses the information provided herein pursuant to the
Securities Market Act and/or the Financial Instruments Trading Act.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.